Medtronic Ups 2027 Outlook Amid Rising Heart Device Demand
Medtronic raises fiscal 2027 forecasts due to strong heart device demand and strategic investments.
Medtronic has increased its fiscal 2027 financial projections, driven by growing demand for its heart devices used in complex cardiovascular procedures. The medical technology giant is capitalizing on the rising adoption of new technologies and a surge in surgical operations.
Strategic Investments and Financial Adjustments
On Tuesday, Medtronic adjusted the lower end of its fiscal 2027 adjusted per-share profit forecast from $5.90 to $5.94, maintaining the upper limit at $6. The company also revised its annual organic revenue growth expectation to a range of 7.25% to 7.75%, up from the previous range of 6.75% to 7.25%.
Medtronic's CEO, Geoff Martha, highlighted the company's confidence in its performance, citing significant contributions from new growth platforms. "It's not just the strength of the quarter but the breadth of performance across our businesses," Martha said during a post-earnings call.
Investments in Innovation
The company announced an $80 million investment in Pi-Cardia, a heart-valve repair device maker, with an option to purchase it for $210 million. Additionally, Medtronic invested $700 million in Cornerstone Robotics, securing rights to distribute a robotic surgical device in select international markets.
These investments align with Medtronic's strategy of focusing on high-growth segments within the medtech industry. Martha noted the potential for growth in soft tissue robotic surgery, particularly in emerging markets where penetration is under 1%.
Cardiovascular Segment Performance
Medtronic's cardiovascular segment reported a 19.5% increase in quarterly sales, reaching $3.93 billion. This growth was largely driven by its pulsed field ablation portfolio, which saw an 88% rise. The company's quarterly adjusted per-share profit stood at $1.45, surpassing analysts' estimates of $1.39, while revenue hit $9.76 billion, exceeding the expected $9.55 billion.
Chief Financial Officer Thierry Pieton mentioned that the company received tariff refunds covering most of the duties paid during the quarter, though these are not factored into future forecasts.